Antibody Test Sarscov2

Human IgG Quick test strip

E411A02-10 10 tests
EUR 150

Human IgG antibody Laboratories manufactures the antibody test sarscov2 reagents distributed by Genprice. The Antibody Test Sarscov2 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Test Group: Sarscov2

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

100 µl
EUR 225

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

1 ml Ask for price

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

200 µl
EUR 350

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

100 µl
EUR 225

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

1 ml Ask for price

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

200 µl
EUR 350

NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test)

40 Tests
EUR 115

Sarscov2 information

Anti SARS-Cov-2 Spike Mab

112056 100 µg Ask for price

Anti SARS-Cov-2 Spike (RBD) Pab

112040 100 µg Ask for price

Anti SARS-Cov-2 Spike (RBD) Mab

112057 100 µg Ask for price

Anti SARS-CoV2-S (Rabbit)

134407 100 µg Ask for price

Anti SARS-CoV2-N (Rabbit)

134408 100 µg Ask for price

Anti SARS-CoV2-S (Mouse) Mab

134415 100 µg Ask for price

Anti SARS-CoV2-N (Mouse) Mab

134416 100 µg Ask for price

Anti SARS-CoV2-O (Mouse) Mab

134417 100 µg Ask for price

SARS-CoV-2 Ag Rapid Test

HSGIA2200A1COV 20 Tests/Kit Ask for price
Description: The SARS-CoV-2 Ag Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in nasal swab specimens from individualswith suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests. Results are for the detection of SARS-CoV-2 Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions. Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. The SARS-CoV-2 Ag Rapid Test is intended for use by self-testing personnel.

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Anti SARS-Cov-2 Orf8, Phosphatase Pab

112041 100 µg Ask for price

Anti SARS-Cov-2 Nucleoprotein Mab

112044 100 µg Ask for price

Anti SARS-Cov-2 Nucleoprotein Pab

272451 100 µg Ask for price

SARS-CoV-2 IgM/IgG Antibody

RT090A 1 Each Ask for price

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-100g 100 µg
EUR 1525

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-20g 20 µg
EUR 187.5

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-50g 50 µg
EUR 337.5